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Abstract
Background: The urinary albumin/creatinine ratio (ACR) is a significant neurologic prognostic predictor in patients
with aneurysmal subarachnoid hemorrhage (SAH). B-type natriuretic peptide (BNP) plays an important role in body
fluid regulation in patients with SAH. The present study was performed to determine whether ACR was
independent predictor for unfavorable neurological outcome and ACR was associated with increased N-terminal
pro-BNP (NT-pro-BNP) after SAH.
Methods: We studied 61 patients undergoing surgery who were admitted within 48 h after aneurysmal SAH onset
between July 2008 and June 2010. Hunt and Hess grade and Fisher grade were recorded at admission. The Glasgow
Coma Scale (GCS) score was calculated at admission and daily for seven postoperative days. Arterial blood was
sampled at admission and for seven postoperative days to determine the PaO2/FIO2 ratio, C-reactive protein level,
troponin I level, and NT-pro-BNP level. Urine was sampled at admission and daily for seven postoperative days to
determine ACR and vanillylmandelic acid/creatinine ratio (VMACR). Neurological outcomes were assessed at hospital
discharge by using the Glasgow Outcome Scale. Receiver operating characteristic curves were constructed for the
predictive variables of unfavorable neurological outcomes, and the area under the curve (AUC) was determined.
Multivariate logistic regression analyses were performed for the significant predictors of unfavorable neurological
outcomes after SAH. Associations with NT-pro-BNP were evaluated by using the Spearman rank correlation test.
Results: Of the 61 patients, 24 had unfavorable outcomes. The prevalence rate of microalbuminuria was 85 % (52/61).
The highest NT-pro-BNP levels were above the normal range in 57 of 61 patients (93 %).
According to the AUC, the Hunt and Hess grade, GCS score, the highest ACR, and highest VMACR were significant
predictors of neurological outcome. Multivariate logistic regression analyses showed that the highest ACR and Hunt
and Hess grade are independent prognostic predictors of unfavorable neurological outcomes. The highest NT-pro-BNP
significantly correlated with the highest troponin I, highest ACR, and VMACR on admission.
Conclusions: The highest ACR is an independent prognostic predictor of unfavorable neurological outcomes after
SAH. Moreover, plasma NT-pro-BNP elevation may be associated with the development of microalbuminuria.
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Background
Patients with aneurysmal subarachnoid hemorrhage (SAH)
[1], intracerebral hemorrhage [2], and cerebral infarc-
tion [3] show a high prevalence of microalbuminuria.
The microalbuminuria, measured by urinary albumin/
creatinine ratio (ACR), is a significant prognostic pre-
dictor in patients with SAH and intracerebral hemorrhage
[1, 2]. However, our previous pilot study did not determine
whether ACR was an independent prognostic predictor in
patients with SAH [1]. Furthermore, the underlying mech-
anism of the association between hemorrhagic stroke and
increased ACR was unclear.
Myocyte stretch leads to the release of a prohormone,
which is subsequently split into B-type natriuretic pep-
tide (BNP) and an N-terminal pro-BNP (NT-pro-BNP),
a biologically inactive molecule. The increase in BNP
levels plays an important role in the regulation of body
fluid in critically ill patients, including patients with
SAH [4]. One study showed that the BNP levels in-
creased gradually over 2 days and returned to normal
within a week after SAH [5]. Plasma BNP and NT-pro-
BNP might be associated with cardiac dysfunction and
myocardial necrosis in the acute phase of SAH [5, 6].
Moreover, microalbuminuria is associated with cardio-
vascular disease in patients with diabetes mellitus [7]
and in the general population [8]. Although an increased
BNP level correlated with microalbuminuria in patients
with diabetes mellitus [9], it is unknown whether this re-
lationship applies to patients with SAH.
The present prospective observational study was per-
formed to determine whether ACR was independent
predictor for unfavorable neurological outcome and the
development of ACR was associated with increased NT-
pro-BNP levels after SAH.
Methods
Patients
The study protocol was approved by the Institutional
Research and Ethics Committee. In accordance with the
Helsinki Declaration, informed consent was obtained
from all patients or the patients’ next of kin. Between
July 2008 and June 2010, we prospectively studied 61
consecutive patients who were admitted to the Nagasaki
Rosai Hospital within 48 h after SAH onset. The exclu-
sion criteria included the presence of renal dysfunction
(serum creatinine level >1.2 mg/dL), which affects ACR
values regardless of changes in glomerular permeability
[10]; no treatment administered for a ruptured aneurysm,
because of poor neurological condition (Hunt and Hess
grade V) or either because the aneurysm was not verified
by cerebral angiography; and continuous postoperative
barbiturate coma, which did not allow the determination
of a Glasgow Coma Scale (GCS) score. An initial com-
puted tomography (CT) scan of the head was performed
on admission. The diagnosis was established on the basis
of the CT scan findings or by observing xanthochromia of
the cerebrospinal fluid when results of the CT scan were
negative. Thereafter, cerebral four-vessel angiography and/
or three-dimensional CT were performed. Surgical clip-
ping of the aneurysm or endovascular surgery was per-
formed at the earliest possible time, as determined by a
team of neurosurgeons experienced in both treatment
modalities. Patients underwent surgery for ruptured aneu-
rysms within 72 h after stroke. Anesthesia was induced
with propofol and fentanyl and maintained with sevoflur-
ane, fentanyl, and vecuronium bromide.
Clinical management
Postoperatively, all patients received conventional brain-
oriented intensive care therapy according to clinical re-
quirements. Normovolemia was maintained through the
systemic administration of an intravenous physiological
electrolyte solution at 1000–2000 mL/day and a colloid
solution as needed. Symptomatic hypovolemia was cor-
rected by the administration of additional fluids, followed
by a continuous infusion of dopamine, as needed—to
maintain a systolic arterial blood pressure of >100 mmHg.
The systolic arterial blood pressure was maintained either
at <160 mmHg in normotensive patients or at <180 mmHg
in hypertensive patients via continuous infusion of nicar-
dipine as needed. Caution was taken to avoid hyperther-
mia (>38.5 °C) and hyperglycemia (>150 mg/dL) through
the administration of diclofenac sodium and insulin as
needed. In mechanically ventilated patients, the arterial
carbon dioxide partial pressure was maintained at 35–
40 mmHg, and the peripheral oxygen saturation was
maintained at >97 %—under sedation with midazolam if
required. Oral and enteral nutrition was initiated as
soon as possible. A CT scan was performed in clinically
deteriorating patients to identify secondary complica-
tions such as hydrocephalus or ischemia. Hypertensive
hypervolemic hemodilution (triple-H) therapy was not
used for prophylaxis. Hydrocephalus was treated with
ventriculostomy. Delayed cerebral ischemia was suspected
in the event of neurological deterioration (two-point de-
crease in the GCS score and/or focal neurological deficits)
and confirmed by cerebral angiography [11]. Hyperten-
sive therapy was reinforced with dobutamine in each
vasospasm episode. The target systolic blood pressure
was 160–180 mmHg. When technically possible, angio-
plasty was performed in patients who failed to respond
to therapy.
Data collection
The following clinical data was collected: age, sex, previ-
ous medical history of hypertension, ischemic heart
disease, heart failure and diabetes mellitus, size and loca-
tion of the aneurysm, and systolic blood pressure. The
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location of the ruptured aneurysms was classified ac-
cording to their presence in the anterior or posterior
circulation [12]. The aneurysm size was categorized as
large (>12 mm) or other [12]. The neurological condi-
tion on admission was scored according to the Hunt and
Hess classification [13]. The amount of blood observed
on the initial CT scan was graded according to the
Fisher classification [14]. The GCS score [15] and sys-
temic inflammatory response syndrome (SIRS) score
[16] were calculated at admission and daily for seven
postoperative days. All physiological variables were re-
corded as the most abnormal value obtained in a day,
except those recorded on admission. Arterial blood was
sampled at admission and for seven postoperative days
to determine the PaO2/FIO2 ratio, C-reactive protein
(CRP) level, troponin I level, and NT-pro-BNP level.
Serum troponine I levels were assayed by using chemilu-
minescence immunoassay (Architect Troponin-I, Abbott
Laboratories, Abbott Park, IL) with an applied threshold
of 0.30 ng/mL for the diagnosis of myocardial necrosis
(a lower limit of detection of 0.01 ng/mL; coefficient
variation, 10 %). Serum NT-pro-BNP levels were assayed
by performing electrochemiluminescence immunoassay
(Roche Diagnostics, Indianapolis, IN) with an applied
threshold of 125 pg/mL (a lower limit of detection of
5 pg/mL; coefficient variation, 10 %). The ACR and
vanillylmandelic acid/creatinine ratio (VMACR) mea-
surements were determined from urine samples col-
lected at admission and daily for seven postoperative
days. We assayed urine vanillylmandelic acid by using
high-performance liquid chromatography with a lower
limit of detection of 0.05 mg/dL and a coefficient
variation of 2.9 %. VMACR values of <5 mg/g were con-
sidered normal. We quantitatively assessed urine albumin
by using an immunonephelometric method (N-antiserum
albumin, Dade Behring, Liederbach, Germany), and we
quantitatively measured urine creatinine by performing an
enzymatic colorimetric test. The sensitivity limit for urine
albumin was 2.3 mg/L; for statistical analyses, values
below this limit were considered to be 0 mg/L. Both inter-
assay and intra-assay coefficient variations were within
5 %. Generally, clinically relevant proteinuria is defined as
an ACR of ≥300 mg/g and microalbuminuria, as an ACR
of 30–299 mg/g; values <30 mg/g are considered normal.
A medical chart review was conducted to determine the
duration of mechanical ventilation, intensive care unit
stay, and hospital stay. The neurosurgeons used the Glas-
gow Outcome Scale (GOS) [17] to assess the neurological
outcomes at hospital discharge. Neurological outcomes
were stratified as unfavorable (GOS score of 1–3: death,
persistent vegetative state, and severe disability) or favor-
able (GOS score of 4 or 5: moderate disability and good
recovery) [1, 18]. In the present study, the intensive care
unit care providers (neurosurgeons and nursing staff )
were blinded to the ACR and NT-pro-BNP values. The
authors were the patients’ anesthesiologists who were
responsible only for blood and urine sampling and the
aforementioned assays.
Fig. 1 The flowchart. Flowchart of patients into study. SAH
subarachnoid hemorrhage








Age 63 (54, 73) 74 (59, 83) 0.03
Female (n) 26 (70.3) 20 (83.3) 0.25
Height (cm) 155 (150, 163) 150 (146, 159) 0.09
Weight (kg) 55 (47, 62) 50 (44, 60) 0.15
Body mass index (cm2) 21.9 (21.0, 24.9) 20.8 (19.7, 24.6) 0.17
Hypertension (n) 14 (37.8) 13 (54.2) 0.21
Ischemic heart disease (n) 1 (2.7) 0 (0) 1.0
Heart failure (n) 0 (0) 1 (4.2) 1.0
Diabetes (n) 1 (2.7) 0 (0) 1.0
Fisher grade 3 (3, 3) 3 (3, 4) <0.01
Hunt and Hess grade 2 (2, 3) 4 (3, 5) <0.01
Large aneurysmal size (n) 3 (8.1) 1 (4.2) 0.65
Posterior aneurysmal
location (n)
6 (16.2) 5 (20.8) 0.65
Admission SBP (mmHg) 158 (140, 169) 149 (122, 174) 0.21
Endovascular surgery (n) 7 (18.9) 9 (37.5) 0.67
Values are median (interquartile range) or number (percentage). Favorable
outcome (Glasgow Outcome Scale: moderate disability and good recovery)
and unfavorable outcome (Glasgow Outcome Scale: death, persistent
vegetative state, and severe disability
SBP systolic blood pressure
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Statistical analysis
Data distributions for the quantitative variables were
expressed as median (interquartile range). Intergroup
comparisons were performed using the Mann-Whitney
U test. Dichotomous variables were analyzed with the
Fisher exact probability test or the chi-squared test. To
assess the predictive value for neurological outcomes,
receiver operating characteristic (ROC) curves were
constructed for each variable and the area under the
ROC curve (AUC) was determined. Predictive variables
were considered significant predictors when the AUC
was >0.8. The threshold value, sensitivity, specificity,
and likelihood ratio of the ACR were compared with
those of some significant predictors of unfavorable
neurological outcomes. Multivariate logistic regression
analyses were performed, including significant predic-
tors and dichotomized by its threshold value base on
ROC analyses with stepwise elimination of valuables
not contributing to the model (p < 0.1). Associations
between the ACR or the NT-pro-BNP level and other
variables were evaluated using the Spearman rank cor-
relation test.
The sample size of 22 patients with SAH per group
(standard deviation, 64 mg/g) was determined on the
basis of our previous study [1], which reflected a power
of 90 % to detect a 100 % difference in the highest ACR
between the two neurological outcomes at a significance
level of 5 %.
Results
During the study period, 67 consecutive patients were
admitted to the ICU within 48 h after aneurysmal SAH.
Of these, we excluded 3 patients who did not receive
any treatment for the ruptured aneurysm due to poor
neurological condition, 2 patients due to renal dysfunc-
tion, and 1 patients who was treated with barbiturate
coma. A flowchart documenting patient’s entry into the
study is shown in Fig. 1.
The prevalence rate of microalbuminuria (>30 mg/g)
was 85 % (52/61). Of the 61 patients enrolled in the
study, 8 (13.1 %) died (GOS score of 1). Of the 53 pa-
tients who were discharged, 16 (26 %) had severe disabil-
ity (GOS score of 3), 11 (19 %) had moderate disability
(GOS score of 4), and 26 (43 %) showed good recovery
(GOS score of 5). Thus, 24 of the 61 study patients
(39 %) had unfavorable outcomes. The highest NT-pro-
BNP levels were above the normal range (125 pg/mL) in
57 of 61 patients (93 %).
Patient characteristics are shown in Table 1. The age,
Fisher grade, and Hunt and Hess grade were higher in
the patients with unfavorable outcomes than in those
with favorable outcomes. Table 2 shows the relationship
Table 2 Relationship between neurological outcome and the selected variables
Variables Favorable outcome Unfavorable outcome p
ACR (mg/g) on admission 64.7 (22.5, 119.3) 222.8 (58.1, 556.6) <0.01
Highest ACR (mg/g) 113.3 (32.7, 220.7) 497.5 (239.6, 1091.7) <0.01
VMACR (mg/g) on admission 5.2 (3.5, 7.8) 9.1 (5.7, 12.2) <0.01
Highest VMACR (mg/g) 5.6 (4.1, 8.1) 10.9 (8.2, 15.3) <0.01
Highest C-reactive protein (mg/dL) 3.4 (1.7, 6.8) 6.9 (1.8, 13.8) 0.02
Highest serum creatinine (mg/g) 0.7 (0.6, 0.8) 0.7 (0.5, 0.9) 0.74
Lowest PaO2/FIO2 ratio 312 (287, 380) 325 (192, 369) 0.24
Highest troponin I (ng/mL) 0.0 (0.0, 0.0) 0.1 (0.0, 0.6) 0.03
NT-pro- BNP on admission (pg/mL) 220 (117, 508) 542 (172, 1732) 0.03
Highest NT-pro-BNP (pg/mL) 703 (238, 1216) 1509 (759, 3438) <0.01
GCS score on admission 15 (13, 15) 10 (7, 14) <0.01
Lowest GCS score 13 (13, 14) 8 (4, 10) <0.01
Highest SIRS score 2 (1, 2) 2 (2, 3) <0.01
Hydrocephalus (n) 13 (8.1) 12 (50.0) 0.25
Delayed cerebral ischemia (n) 9 (24.3) 12 (50.0) 0.04
Lung edema (n) 7 (18.9) 9 (37.5) 0.11
Ventilation days 0 (0, 1) 5 (1, 15) <0.01
Intensive care unit days 14 (12,16) 16 (12, 21) 0.10
Hospital days 40 (24, 53) 53 (25, 74) 0.29
Values are median (interquartile range) or number. Favorable outcome (Glasgow Outcome Scale: moderate disability and good recovery) and unfavorable
outcome (Glasgow Outcome Scale: death, persistent vegetative state, and severe disability)
ACR urinary microalbumin/creatinine ratio, VMACR urinary vanillylmandelic acid/creatinine ratio, NT-pro-BNP N-terminal pro-Brain natriuremic peptide, GCS Glasgow
Coma Scale, SIRS systemic inflammatory response syndrome
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between neurological outcomes and selected laboratory
variables. The ACR on admission, highest ACR, VMACR
on admission, highest VMACR, highest CRP level, high-
est troponin I, NT-pro-BNP level on admission, and
highest NT-pro-BNP level were higher in patients with
unfavorable neurological outcomes than in those with
favorable neurological outcomes. The GCS score on ad-
mission and the lowest GCS score were lower in the pa-
tients with unfavorable outcomes than in those with
favorable outcomes. The highest SIRS score, the preva-
lence delayed cerebral ischemia, and mechanical ventila-
tion duration were higher in the patients with unfavorable
outcomes than in those with favorable outcomes.
The AUC was >0.8 for the Hunt and Hess grade, GCS
score on admission, lowest GCS score, highest ACR, and
highest VMACR (Table 3). Table 4 shows a comparison
of the predictive characteristics of the significant predic-
tors of neurological outcomes in patients with SAH.
Table 5 summarizes the results of multivariate logistic
regression analyses of these five significant predictors
based on ROC. The results shows the ACR (>280 mg/g)
and Hunt-Hess grade (>3) are independently associated
with unfavorable neurological outcome.
The highest ACR was significantly correlated with the
age (r = 0.42), Hunt and Hess grade (r = 0.49), GCS score
on admission (r = −0.49), lowest GCS score (r = −0.56),
highest CRP level (r = 0.41), highest SIRS (r = 0.51), high-
est troponin I level (r = 0.47), ACR on admission (r =
0.77), VMACR on admission (r = 0.53), highest VMACR
(r = 0.51), NT-pro-BNP level on admission (r = 0.39),
highest NT-pro-BNP level (r = 0.56), mechanical ventila-
tion duration (r = 0.53), and GOS score (r = 0.62). The
highest NT-pro-BNP level was significantly correlated
with the highest troponin I level (r = 0.62), NT-pro-BNP
level on admission (r = 0.63), highest ACR (r = 0.56), and
VMACR on admission (r = 0.53).
Discussion
The results of the present study suggest that plasma
NT-pro-BNP elevation may associated with the develop-
ment of microalbuminuria as well as cardiac injury and
sympathetic nervous system activation after SAH, be-
cause the highest NT-pro-BNP level was significantly
correlated with the highest ACR, highest troponin I
level, and VMACR on admission. Moreover, our findings
show that the ACR and the Hunt and Hess grade are
independent prognostic predictors of unfavorable neuro-
logical outcomes after SAH.
The BNP concentrations increased in critically ill
patients [19]. The highest BNP concentrations were ob-
served in patients who underwent cardiac surgery proce-
dures and in patients with SAH. Elevated BNP levels are
associated with myocardial necrosis, pulmonary edema,
and systolic and diastolic dysfunction of the left ventricle
after SAH [6]. On the other hand, an echocardiographic
study showed that plasma BNP was associated with
myocardial necrosis but was unrelated with systolic and
diastolic cardiac function [4]. The present study showed
that the plasma NT-pro-BNP levels were associated with
myocardial necrosis evaluated by troponin I levels. How-
ever, it was not unclear whether the plasma NT-pro-
BNP levels were associated with systolic and diastolic
cardiac dysfunction, because we did not conduct the
echocardiographic analysis. The heart is the primary
source of elevated BNP levels after SAH [6]. However,
the correlation between the BNP elevation and illness
severity or mortality is controversial.
The present study showed that plasma NT-pro-BNP
levels were associated with VMACR levels. The increase
in BNP levels after SAH owing to increased cardiac
production may have been triggered by stress-induced
noradrenaline release [20]. Moreover, hypothalamus le-
sions caused by SAH may induce expanded cardiac BNP
production. The overactivity of the sympathetic nervous
system is a common phenomenon that links the major
cardiac pathologies observed in neurological disorders.
The stimulation of the hypothalamus can lead to auto-
nomic cardiovascular disturbances, known as the “the
brain-heart connection” [21].
Moreover, the present study showed that plasma NT-
pro-BNP levels were related to ACR. Yano et al. showed
that the increased plasma BNP levels were correlated
with the urinary albumin excretion rate in normotensive
patients with diabetes mellitus [9]; however, contrasting
Table 3 The area under the receiver characteristics curves
constructed for each of the predictive variables of neurological
outcome at hospital discharge
Variables Area (95 % CI)
Hunt and Hess grade 0.81 (0.69–0.93)a
Fisher grade 0.70 (0.57–0.83)
Glasgow Coma Scale score on admission 0.83 (0.72–0.94)a
Lowest Glasgow Coma Scale 0.87 (0.77–0.97)a
Delayed cerebral ischemia 0.63 (0.48–0.78)
Highest troponin I 0.67 (0.52–0.82)
Highest systemic inflammatory response
syndrome score
0.70 (0.57–0.83)
Urinary albumin/creatinine ratio on admisssion 0.75 (0.62–0.88)
Highest urinary albumin/creatinine ratio 0.84 (0.73–0.95)a
Urinary vanillylmandelic acid/creatinine ratio
on admission
0.75 (0.63–0.87)
Highest urinary vanillylmandelic acid/creatinine ratio 0.82 (0.71–0.93)a
N-terminal pro brain natriuremic peptide on admission 0.67 (0.52–0.82)
Highest N-terminal pro brain natriuremic peptide 0.73 (0.60–0.86)
Area area under the receiver characteristics curve, CI confidence interval
aEach predictive variable was defined as a significant predictor when areas
of the variables were more than 0.8
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results were reported by Asakawa et al. [22]. Although
the relationship between BNP and microalbuminuria
levels remains unclear in patients with diabetes mellitus,
the infusion of atrial natriuretic peptide increases the
urinary excretion of albumin in patients with diabetes
mellitus [23]. Atrial natriuretic peptide is known to exert
a vasodilatory effect on the afferent arteries and a vaso-
constrictor effect on the efferent arteries of the glomeruli,
thereby increasing the glomerular hydraulic pressure.
Given that BNP and atrial natriuretic peptide bind to the
same receptor and have the same biological activity, the
elevated levels of BNP cause an increase in the glomerular
hydraulic pressure and ultimately induce albumin excre-
tion in patients with diabetes mellitus [9].
Age, admission neurological grade, history of hyper-
tension, systolic blood pressure at admission, ruptured
aneurysm location and size, blood clot thickness on CT
scans, and angiographic vasospasm at admission are rec-
ognized as neurological prognostic factors in multicenter
clinical study with a large number of aneurysmal SAH
patients [12]. Delayed cerebral ischemia, intraventricular
hemorrhage, rebleeding, medical complication including
fever, anemia, hypertension, respiratory failure and car-
diac complication, and the SIRS score and Acute
Physiology and Chronic Health Evaluation 2 score were
associated with neurological outcome in SAH patients
[16, 24–27]. The present results show that among
these prescribed predictors, the highest ACR and the
Hunt-Hess grade are the independent predictors of
neurological outcome. However, Hunt-Hess grade is a
subject assessment. Measurement of the ACR during
first 8 days may provide objective and reliable informa-
tion for the neurological outcome in the SAH patients.
Limitations
Although we measured ACR in a spot urine sample,
Gansevoort et al. [28] showed that the diagnostic per-
formance of measuring ACR in a spot urine sample in
predicting microalbuminuria in a subsequent 24-h urine
collections was clinically satisfactory.
This study showed the significant and moderate corre-
lations between the ACR and the plasma NT-pro-BNP.
It is unclear whether plasma NT-pro-BNP elevation con-
tributes to the development of microalbuminuria in this
study results. Further studies are necessary to clarify the
exact relationship between plasma NT-pro-BNP eleva-
tion and the development of microalbuminuria in the
SAH patients.
Conclusions
The highest ACR is an independent prognostic predictor
of unfavorable neurological outcomes. Although the
mechanism of the development of microalbuminuria in
unfavorable neurological patients after SAH is unknown
at present, this study provided the information that the
plasma NT-pro-BNP elevation might be associated with
the development of microalbuminuria after SAH. Fur-
ther studies are necessary to better understand the
mechanism of the development of microalbuminuria in
the SAH patients.
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Table 4 Comparison of significant predictor’s characteristics that predict unfavorable neurologic outcome at hospital discharge after
subarachnoid hemorrhage
Variables Threshold value Sensitivity (95 % CI) (%) Specificity (95 % CI) (%) Likelihood ratio (95 % CI)
Hunt-Hess grade >3 58 (52–64) 92 (89–95) 7.2 (4.0–13.0)
Highest ACR (mg/g) >280 63 (56–69) 97 (95–99) 23.1 (12.7–42.1)
GCS score on admission <10 42 (36–48) 97 (95–99) 15.4 (9.5–25.0)
Lowest GCS score <9 42 (33–67) 97 (95–99) 15.4 (9.5–25.0)
Highest VMACR (mg/g) >14 38 (32–44) 97 (95–99) 13.9 (8.7–22.3)
Unfavorable outcome (Glasgow Outcome Scale: death, persistent vegetative state, and severe disability)
CI confidence interval, ACR urinary albumin/creatinine ratio, GCS Glasgow Coma Scale, VMACR urinary vanillylmandelic acid/creatinine ratio
Table 5 Multivariate logistic regression analyses of predictive
factors for unfavorable neurologic outcome at hospital
discharge after comparison of the predictive characteristics of
the significant predictor
Variables Threshold value Odds ratio (95 % CI) p
Hunt-Hess grade >3 19.2 (1.7–217.2) 0.02
Highest ACR (mg/g) >280 30.7 (3.3–284.4) 0.01
GCS score on admission <10 1.1 (0.1–27.1) 0.96
Lowest GCS score <9 1.3 (0.1–14.5) 0.86
Highest VMACR (mg/g) >14 1.5 (0.1–19.0) 0.74
Unfavorable outcome (Glasgow Outcome Scale: death, persistent vegetative
state, and severe disability)
CI confidence interval, ACR urinary albumin/creatinine ratio, GCS Glasgow
Coma Scale, VMACR urinary vanillylmandelic acid/creatinine ratio
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